Different treatment modalities for advanced laryngeal cancer: improvement of oncological outcomes after tumor board implementation

晚期喉癌的不同治疗方式:肿瘤委员会实施后肿瘤治疗效果的改善

阅读:1

Abstract

INTRODUCTION: Laryngeal Squamous Cell Carcinoma (LSCC) has several treatment modalities available. Contrary to what has been observed in other cancers, the survival rates have worsened in recent years. METHODS: Retrospective cohort study evaluating patients with T3 and T4a LSCC divided into two groups: those who were submitted to Total Laryngectomy (TL) or to Chemoradiation (CRT) or radiotherapy alone with curative intent between 2009 and 2019. RESULTS: Three hundred and twenty patients were considered eligible to participate in the study, of which 166 (51.87%) submitted to TL and 154 (48.12%) to CRT. Overall survival in the surgical group was higher compared to the CRT group only between 2009 and 2013. In 2014, a multidisciplinary meeting was organized at the institution where the study took place, and both treatment modalities reached similar oncological outcomes. CONCLUSION: Multidisciplinary discussion among experienced professionals has a positive impact on oncological outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。